You are here: Industry Insights > COVID-19

News List

Multiple Myeloma Patients Display Weakened Antibody Responses to mRNA COVID Vaccines firstwordpharma
August 02, 2021
A new study reports weakened antibody responses to COVID-19 mRNA vaccines among most patients with multiple myeloma, a common form of bone-marrow cancer associated with an immunocompromised state.
Russia’s global vaccine ambitions stumble during supply shortage firstwordpharma
August 02, 2021
Deliveries of Russia's Sputnik V COVID-19 vaccine have been hampered, forcing countries to seek alternatives, Bloomberg reported.
CytoSorbents Completes its Mission 100,000 International Fundraising Campaign to Fight the Spread of COVID-19 for Global Humanitarian Organization, CARE prnewswire
August 02, 2021
CytoSorbents Corporation announces the successful completion of its MISSION 100,000 international fundraising campaign to fight the spread of COVID-19, raising $100,000 to benefit the global, not-for-profit humanitarian organization, CARE.
QPS Supports COVID-19 Vaccine Development In Taiwan, China prnewswire
August 02, 2021
QPS, a global contract research organization (CRO) focused on bioanalytics and clinical trials, is honored to have collaborated with Medigen Vaccine Biologics Corporation to complete toxicology studies necessary for the development of a COVID-19 vaccine.
As Delta Variant Surges, Medicomp Systems Cancels Participation in HIMSS21 prnewswire
August 02, 2021
Medicomp Systems, which makes medical data relevant, usable and actionable, today announced that it is canceling its participation in the HIMSS21 Global Health Conference & Exhibition, August 9-13, 2021, in Las Vegas.
New study provides insight into the pharma industry’s reputation in the UK pharmatimes
July 30, 2021
New research from the Association of the British Pharmaceutical Industry (ABPI) and Ipsos MORI reveals attitudes to the pharmaceutical industry in the UK, including perceptions of healthcare professionals (HCPs), the public and members of parliament.
Rho Granted Extension by NIAID to Study Rate of COVID-19 Infection in US Children americanpharmaceuticalreview
July 30, 2021
Rho announced its Human Epidemiology and Response to SARS-CoV-2 (HEROS) study, to help determine the rate of the new coronavirus infection in children and their families in the U.S. has been extended through April 2022.
FDA Authorizes New Standalone Treatment for COVID-19 americanpharmaceuticalreview
July 30, 2021
The U.S. FDA revised the Emergency Use Authorization (EUA) for baricitinib (sold under the brand name Olumiant) now authorizing baricitinib alone for the treatment of COVID-19 in hospitalized adults and pediatric patients two years of age or older ...
Covishield gives 93 per cent protection against COVID and 98 per cent mortality reduction: AFMC expresspharma
July 30, 2021
Addressing a press conference, Dr V K Paul, Member (Health), NITI Aayog, presented findings of the study which was conducted on 15 lakh doctors and frontline workers.
Type 2 Diabetes in Teens Can Bring Dangerous Complications in 20s drugs
July 30, 2021
Children diagnosed with type 2 diabetes face a high likelihood of developing complications before age 30, a new study suggests.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page